RYAN MACKINNON VASAPOLI AND BERZOK, LLP for GENENTECH
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| NICK KOLOVOS | — |
| JEFF MACKINNON | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Food Industry (safety, labeling, etc.) FOO
Monitor food safety and supply chain issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| NICK KOLOVOS | — |
| JEFF MACKINNON | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Health Issues HCR
Physician payment disclosure including S. 301; Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for Americans Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life Savings Medicines Act; H.R. 3962, Affordable Health Care for America Act; Comparative effectiveness legislation including S. 1213; Patient-Centered Outcomes Research Act of 2009; H.R. 3200, America's Health Future Act; H.R. 1548- Pathway for Dissimilar Act; Legislative changes in the health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act."; S. 1679, Affordable Health Choice Act; S. 1796, America's Healthy Future Act of 2009; Pharmaceutical import safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW BERZOK | — |
| NICK KOLOVOS | — |
| JEFF MACKINNON | — |
| THOMAS RYAN | — |
| JOSEPH V VASAPOLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.